Olfactory ensheathing cells (OECs) are a type of specialized glial cell currently considered as having a double function in the nervous system: one regenerative, and another immune. Streptococcus pneumoniae is a major agent of severe infections in humans, including meningitis. It is commonly found in the nasopharynx of asymptomatic carriers, and, under certain still unknown conditions, can invade the brain. We evaluated whether pneumococcal cells recovered from lysed OECs and microglia are able to survive by manipulating the host cell activation. An intracellular-survival assay of S. pneumoniae in OECs showed a significant number of bacterial CFU recovered after 3 h of infection. In contrast, microglia assays resulted in a reduced number of CFU. Electron-microscopy analysis revealed a large number of pneumococci with apparently intact morphology. However, microglia cells showed endocytic vesicles containing only bacterial cell debris. Infection of OEC cultures resulted in continuous NF-κB activation. The IFN-γ-induced increase of iNOS expression was reversed in infected OECs. OECs are susceptible to S. pneumoniae infection, which can suppress their cytotoxic mechanisms in order to survive. We suggest that, in contrast to microglia, OECs might serve as safe targets for pneumococci, providing a more stable environment for evasion of the immune system.
Olfactory ensheathing cells (OECs) are a type of specialized glial cell that accompany and ensheath the primary olfactory axons through the olfactory pathway, from the olfactory epithelium to the olfactory tract. OECs are essential for olfactory axonal outgrowth and guidance within the developing and adult olfactory system1,2. This property of OECs makes them an outstanding candidate for cellular therapy to stimulate central nervous system (CNS) repair after injury3. However, to create a favourable microenvironment for neurogenesis, the OECs must interact with the lesion site in order to avoid triggering more aggressive responses than those caused by the initial damage. Previous studies have focused on improving the understanding of the immunomodulatory mechanisms of OECs during neurological disorders, including those caused by pathogens4,5,6,7.
Streptococcus pneumoniae is a major bacterial agent of severe infections in humans, including meningitis. This microorganism is commonly found in the nasopharynx of asymptomatic carriers, and, under certain still largely unknown conditions, can become pathogenic and invade the CNS8,9. The mechanism by which some strains of S. pneumoniae gain access to the brain without being able to survive in the bloodstream remains unknown. Some evidence points to a non-hematogenous invasion of the brain by S. pneumoniae, through transport along the olfactory bulb (OB)10. Recent data from our group confirmed these findings, by detecting S. pneumoniae DNA in the OB of bacteria-challenged mice11. Although several lines of evidence indicate that S. pneumoniae reaches the OB, based on the use of molecular techniques for the detection of bacterial DNA and specific pneumococcal antigens, no data are available to support the idea that the bacteria can survive in the OB cells and therefore be able to spread the infection through the CNS. In the present study, we evaluated whether pneumococci recovered from lysed OECs and from microglia cells are able to survive by manipulating the host cell to favor their continuity in a less-hostile environment.
In vitro infection of S. pneumoniae in OECs or microglia cultures
The occurrence of S. pneumoniae infection was analyzed after interaction with OECs for 3 h. S. pneumoniae was detected by using pneumococcal anti-serum. The results revealed a variable number of internalized bacterial cells throughout the cytoplasm of OECs, which were identified by the phenotypic marker p75NRT (Fig. 1a,b).
Ultrastructural analysis of infected OECs or microglia cells by transmission electron microscopy revealed the presence of a large number of S. pneumoniae attached to the plasma membrane or internalized in endocytic vesicles in different regions of the OEC cytoplasm (Fig. 2a–c). The bacteria internalized in endocytic compartments of OECs showed apparently intact morphology (Fig. 2a,c), in striking contrast to that observed in N13 cells under the same conditions of infection (Fig. 2d–f). After 3 h of interaction with S. pneumoniae, N13 cells contained only bacterial cell debris within large vacuoles, compatible with intracellular digestion process (Fig. 2e,f).
S. pneumoniae entry and survival in OECs but not in microglia
We evaluated the kinetics of association (adhesion or internalization) of S. pneumoniae with OECs or N13 cells, washing the infected cultures and then lysing them in buffers for different interaction times of 1, 3 and 5 h. The counts of the colonies formed after plating the OECs lysates showed no significant differences between these interaction times, revealing that the number of OECs containing adhered and/or internalized S. pneumoniae did not vary over short intervals of interaction (Fig. 3a).The intracellular survival assay with the exclusion of S. pneumoniae attached to the plasma membrane of OECs through treatment with an antibiotic showed a significant number of CFU from bacteria recovered after 3 h of infection, followed by lysis of the host cell (Fig. 3b). On the other hand, the same test performed with N13 cells resulted in a reduced number of CFU from bacteria recovered after 3 h of infection (Fig. 3b).
S. pneumoniae induces continuous NF-κB p65 activation in OECs
Infection of the OEC cultures with S. pneumoniae for up to 3 h resulted in continuous nuclear translocation of NF-κB. After 10 min of infection, the majority of the OECs showed a massive nuclear translocation of NF-κB. In contrast, intense NF-κB labeling was observed in the cytoplasm from control uninfected OEC cultures maintained under the same conditions (Fig. 4a,b).
In vitro regulation of iNOS expression in OECs
In our culture system, the OECs phenotypically identified by the expression of αSMA were capable of expressing iNOS even in the absence of any stimulus (Fig. 5a,b). We observed no significant differences in the expression of iNOS after treatment of OECs with poly B (Fig. 5c). Incubation of OECs with FSK appears to have had little or no effect (Fig. 5d). Furthermore, OEC cultures incubated with FSK showed a marked change in morphology, displaying an elongated fusiform shape (Fig. 5d). This morphological pattern was not changed by polyB (Fig. 5e). S. pneumoniae infection of OECs, phenotypically identified by the expression of P75NRT, was able to reduce the expression of iNOS (Fig. 5h,i) compared to uninfected cultures (Fig. 5f,g). This negative regulation of expression of the iNOS by S. pneumoniae was confirmed by quantitative RT-PCR analysis; iNOS expression was significantly higher in uninfected control OEC cultures than in infected cultures in the same conditions for 3 h (Fig. 6j). Incubation of the microglia cultures with poly B or FSK did not result in any changes similar to those observed in the OEC cultures (data not shown).
S. pneumoniae modulates iNOS expression by OEC IFN-γ-treatment
Because iNOS is involved in the responses to host cell infection by S. pneumoniae, we tested whether iNOS could be modulated during infection of OECs or N13 cells. Treatment of the cultures with rIFN-γ (100 U/mL) resulted in a substantial increase in iNOS expression by OECs after 18 h of stimulation (Fig. 6a1) compared with untreated OEC cultures (Fig. 6b1). On the other hand, the increase in IFN-γ-induced iNOS expression was reversed in cultures infected by S. pneumoniae for an additional period of 3 h (Fig. 6c).
Treatment of cultures with IFN-γ for 18 h prior to infection by S. pneumoniae significantly reduced the percentage of infected OECs, compared to control cultures maintained for the same period in medium alone (Fig. 6d). These data suggest a reduction in the endocytic activity of the OECs via downregulation of Mannose Receptor (MR) expression, considering that proinflammatory reagents, such as interferon-gamma (IFN-γ), suppress this expression12. To test this hypothesis, we treated OEC cultures with IFN-γ and then added the MR antibody. Treatment of OECs with IFN-γ for 18 h significantly reduced the expression of MR (Fig. 6a3) compared to the untreated control cultures (Fig. 6b3). Since iNOS is involved in the production of microbicidal products such as NO, we investigated whether infection by S. pneumoniae affects the levels of NO in OECs or N13 cells. Neither uninfected nor infected OEC cultures increased the production of NO, which remained below the detection limit in all the time intervals. In contrast, N13 microglia showed a significant increase in NO levels after 1 h of infection, but NO levels then declined to below the detection limit after 3 and 5 h of infection (Fig. 6e).
Previous studies have shown that the OECs increase the in vitro content of iNOS after challenge by bacteria such as Escherichia coli and Staphylococcus aureus5,6. In opposition to other reports, our data revealed that OECs infected with S. pneumoniae for a period of 3 h showed an apparent reduction of iNOS levels compared to uninfected OECs. In spite of this, our results suggest that S. pneumoniae may negatively regulate iNOS, allowing the establishment of infection. As far as we are aware, OECs do not appear to have the same microbicidal activity of professional phagocytes, failing to destroy the internalized bacteria. The down-regulation of iNOS expression in OECs induced through the S. pneumoniae infection can be attributed to a variety of factors, including: i) the ability of these bacteria to cause protein degradation, in this case, iNOS; ii) the ability of S. pneumoniae to secrete endonucleases to cleave the mRNA sequences involved in transcriptional regulation of iNOS13.
This biphasic response of OECs to different groups of bacteria can be attributed to the characteristics of each of them, and in our case it is not surprising that highly pathogenic strains of S. pneumoniae such as EF3030 are capable of suppressing the cellular activation mechanism. The same situation may not occur in professional phagocytes, such as microglia, where pathogenic bacteria would be rapidly killed and efficiently degraded after they invade, preventing the establishment of infection.
The OECs obtained by our culture method expressed iNOS constitutively. This finding was unexpected since this protein requires stimulation by endogenous or exogenous agents for its expression in non-professional phagocytes. Initially, we suspected contamination by LPS, but this possibility was discarded as incubation of the cultures with poly B did not alter the results. In another experiment, we found no substantial differences between this “constitutive” and induced (stimulation with 100 U/mL IFN-γ) expression of iNOS by OECs. However, additional studies are necessary to better understand this mechanism involved in the activation of iNOS in OECs.
NF-κB is an important transcription factor involved in the synthesis of proinflammatory molecules such as iNOS. Therefore, NF-κB translocation is essential to produce iNOS, and consequently to release NO from the cell. Inorganic anion nitrite (NO2−) is an end product of endogenous NO metabolism, and its presence has a crucial role in NF-κB inhibition14. As long as NO is produced, the concentration increases, preventing NF-κB translocation. We evaluated the translocation of NF-κB in order to test whether this might be one of the mechanisms by which the pneumococci can downregulate the expression of iNOS, considering that it was previously reported that NF-κB remains translocated in the absence of NO. In fact, Harris et al. showed that NF-κB remains translocated in the presence of inhibitors of NO production, suggesting the existence of a negative feedback loop between NF-κB and NO6. Our studies with NF-κB activation during the kinetics of the association of S. pneumoniae with OECs showed that it remains translocated in the nucleus for 10 to 180 min of interaction. These results are consistent with the reduced expression of iNOS and low nitrite levels found in infected OEC cultures. Collectively, these data suggest a possible mechanism triggered by S. pneumoniae that is able to suppress the pathway for expression of iNOS and therefore the production of NO. Furthermore, recent data from our group suggest the existence of a soluble factor that is generated after interaction of S. pneumoniae with OECs, which can simultaneously be able to regulate NF-κB activation and the viability of microglia11. However, continued studies are necessary to better understand the influences of S. pneumoniae on the biosynthetic pathway for NO production, and its impact on continuous NF-κB p65 activation in OECs.
It is largely known that proinflammatory cytokines such as IFN-γ negatively regulate the expression and activity of MR12,15; and we found a similar result in OECs, with a drastic reduction of MR expression after treatment with IFN-γ. Our findings showed that the percentage of OECs infected by S. pneumoniae decreased substantially after the cultures were treated for 18 h with IFN-γ, supporting our previous data indicating a possible involvement of MR in the internalization of S. pneumoniae. Nevertheless, we cannot rule out the possibility that other factors are involved in the reduction of infection, such as the activation of iNOS also induced by INF-γ.
The intracellular viability assay revealed a large number of CFU of S. pneumoniae internalized by the OECs, at different interaction times (1, 3 and 5 h). This contrasted with the results obtained for microglia cells, in which only a small number of CFU were observed, demonstrating that OECs can provide a much more permissive environment for intracellular survival of S. pneumoniae. In these assays we found that the viability of S. pneumoniae was not compromised, and also there were no significant differences among the times evaluated, which reinforces our hypothesis that OECs function as host cells for this pathogen. Supporting this hypothesis, our results showed that pneumococcal infection drives microglia into a potentially lethal function, increasing NO levels, which in turn can be suppressed by reduction of the infection load. These data contrast markedly with our observations on OECs, which remained unresponsive and did not increase their production of NO during the course of the infection.
Ultrastructural analysis after interactions for 3 h showed adherent pneumococci on the cellular surface and also in plasma membrane expansions, suggestive of recent engulfment by OECs due to self-induced bacterial invasion. Three hours after the interaction, a few vacuoles in the cytoplasm of the microglia were observed, containing still-undigested bacteria. Thus, the gradual decrease in bacterial load could be related to a low ability of microglia to harbor S. pneumoniae infection.
Recent studies support the hypothesis that OECs could play a role in the innate immune response, assuming a role in the front-line defense of the olfactory system against bacterial infections, due to their ability to detect and confine pathogens4,5,16. Olfactory ensheathing cells (OECs) are a type of specialized glial cell, currently considered as having a double function in the nervous system: one regenerative, essential for axonal outgrowth and guidance; and another immune, as phagocytes involved in the engulfment of pathogens and cell debris16,17. Although they are not considered professional phagocytes, OECs seem to play an important role in tissue clearance, considering that they have a range of receptors for pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs)4,5,7.
Our data provide some clues about a possible OEC function as a mediator of S. pneumoniae invasion of the CNS. Pneumococcal meningitis usually develops through various stages of interaction between the bacteria and the host cell, including the initial steps, from the survival of pneumococci and the subsequent invasion of the CNS18.
Taken together, the results of the present study showed for the first time that S. pneumoniae resists intracellular killing and prevents OECs activation. Increased intracellular survival of S. pneumoniae may be a passive strategy to evade the host’s microbicidal mechanisms, avoiding attack by immune cells such as microglia, by hiding the bacterium inside the OECs (Fig. 7). Continued studies are necessary to further elucidate the immune defense mechanisms regulating the function of OECs and their interaction with S. pneumoniae, as they represent a potential line of defense against infectious pathogens in the OB. On the other hand, the presence of a glial cell type near axons projecting from the olfactory epithelium to the OB, susceptible to the counter-regulation of its immunological function by pathogens, could create a route that potentially renders the CNS more vulnerable to infection by S. pneumoniae strains that may fail to survive in the bloodstream.
Primary OECs cultures
Primary rat OEC cultures were obtained by the procedure described by Nash et al.19, as modified by our group7,20. Eight-week-old male Wistar rats were obtained from the Center for Experimental Surgery Laboratory at the Federal University of Rio de Janeiro. Animal care, all experiments, and euthanasia were approved by the Ethics Committee for Laboratory Animal Use in Research of the Federal University of Rio de Janeiro (CEUA - UFRJ), Permit Number: 01200.001568/2013–87 in accordance with the International Guiding Principles for Biomedical Research Involving Animals, recommended by the World Health Organization (Committee, 2011)21. The cells were plated in the desired density into the appropriate laminin-coated flasks (Sigma Chemical, St. Louis, MO, USA), plates or wells in DMEM/F12 medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% heat-inactivated fetal calf serum (FCS; Cultilab, Campinas, SP, Brazil), 2 μM forskolin (FSK; Calbiochem, La Jolla, CA, USA), and 20 μg/mL bovine pituitary extract (BPE – Biomedical Technologies, Massachusetts, MA, USA), 1 mM glutamine (Biofluids Inc., Rockville, Maryland, USA), 100 U/mL penicillin, and 50 μg/mL streptomycin (Invitrogen, Carlsbad, CA, USA). The cells were kept at 37 °C in 5% CO2, and the medium was changed regularly.
Microglia cell line culture
The N13 microglia cell line22 was kindly provided by Dr. Claudia Verderio (Department of Medical Pharmacology, CNR Institute of Neuroscience, University of Milan, Milan, Italy). Cells were cultured in RPMI 1640 medium (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 2 mM glutamine, 10% fetal calf serum, 100 U/mL penicillin and 50 μg/mL streptomycin. Flasks were maintained at 37 °C in a humidified atmosphere containing 5% CO2.
The encapsulated strain of S. pneumoniae (EF3030, serotype 19F) used in the present study was kindly donated by Dr. David E. Briles (University of Alabama, Birmingham, AL, USA). The EF3030 strain was selected for performing interaction assays with OECs based on the fact that it colonizes the upper respiratory tract in the absence of spreading through the bloodstream23 and it belongs to a serotype frequently associated with resistance to penicillin and other antimicrobial agents24.
Phenotypic identification of OECs
For phenotypic identification of OECs in uninfected and infected cultures, the fixed cultures were incubated with rabbit polyclonal anti-p75 neurotrophin receptor antibodies (p75 NTR –1/400, Sigma) and an anti-smooth muscle α-Actin (anti-SM α-Actin – 1/100, Sigma). After reaction with the primary antibodies of interest, cells were incubated with goat anti-rabbit IgG and sheep or goat anti-mouse IgG secondary antibodies, labeled with either Alexa 488 or Cy3 (Life Technologies; Invitrogen, Carlsbad, CA, USA), washed in pH 7.4 PBS, mounted with N-propylgallate (Sigma) in PBS–glycerol and coverslipped.
Assays of association and intracellular survival of S. pneumoniae in OECs or microglia
Association assays were performed in order to determine the total number of S. pneumoniae associated (both adhered and internalized bacteria) with OECs after 1, 3 and 5 h of interaction. This assay was conducted without antibiotics. For the intracellular survival assay, OECs or microglia were infected at a multiplicity of infection of 100:1 (bacteria:cell) with strain EF3030 in serum- and antibiotic-free DMEM/F-12. Cells were incubated for 3 h at 37 °C, and then free bacteria were removed by five washes with serum-free DMEM. The infected cultures were rinsed with 2% penicillin-streptomycin solution (Invitrogen, Carlsbad, CA, USA) for 1 h to kill S. pneumoniae cells adhered to the cellular surface. After this period, 3 washes were done and the cell cultures were lysed with 20 μM digitonin, serially diluting the contents of each well in Blanks buffer-PRAS, and plated onto sheep blood agar plates (Plast Labor, Rio de Janeiro, RJ, Brazil) for enumeration of colony-forming units (CFU).
Interaction of S. pneumoniae with OECs or microglia cultures
When the cell cultures reached semi-confluence, interaction assays with S. pneumoniae were performed as previously described in detail7. After repeated washing to remove any residual FCS, the OEC cultures were infected for up to 5 h at 37 °C with suspensions of living S. pneumoniae cells in serum- and antibiotic-free DMEM/F-12. S. pneumoniae cells were detected by using a pneumococcal anti-serum (OMNI States Serum Institute, Copenhagen, Denmark) and/or stained with 0.1 mg/mL 4′,6-diamidinophenylindole (DAPI, Sigma) as already described7.
In order to investigate NO production, culture supernatants from uninfected and infected OEC or N13 cell cultures maintained for periods of 1, 3, and 5 h were analyzed for their nitrite content, using the Griess reaction. Highly purified bovine serum albumin (BSA) at 2% concentration was tested in place of fetal bovine serum (FBS) during the NO measurement and infection protocols. The supernatants, collected previously, were filtered through 0.22 μm pore membranes, aliquoted and stored at −80 °C. The concentration of nitrite, a stable metabolite of nitric oxide (NO), was measured in culture supernatants by the Griess assay as described earlier25. After 10 min incubation at room temperature, the optical density of a 1: 1 mixture of supernatant (100 μL) and Griess reagent (100 μL) was measured in a microtiter plate reader (Flow, Meckenheim, Germany) at 546 nm against a blank consisting of the medium without phenol red. A sodium-nitrite standard curve (0–100 mM) was generated in parallel.
For some samples, the infection was followed at 10, 20, 40, 60, and 180 min by fixation with 4% paraformaldehyde in PBS for 30 min at room temperature. After permeabilization of the cells with 0.3% PBS–Triton and blocking with 10% normal goat serum (NGS), the cultures were incubated with a rabbit polyclonal anti-nuclear factor-kappa B (NF-κB) p65 antibody (1:500; Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit polyclonal anti-mannose receptor (1:100; Abcam, Cambridge, MA, USA) or with a rabbit anti-inducible nitric oxide synthase (iNOS) antibody (1:200; Cell Signaling Technology, Beverly, MA, USA). After the reaction with the primary antibodies of interest, cells were incubated with goat anti-rabbit IgG and sheep or goat anti-mouse IgG secondary antibodies, labeled with either Alexa 488 or Cy3, mounted with N-propylgallate in PBS-glycerol and coverslipped. To circumvent any potential bias that could induce iNOS expression in our culture system, such as contamination with outer-surface membrane lipopolysaccharides (LPS) that are present in almost all Gram-negative bacteria, we used polymyxin B (poly B; Sigma) as an inhibitor of LPS. Some assays were performed in the presence of 10 μg/mL of poly B. Since FSK increases the enhancement of LPS-induced iNOS expression in another type of glial cell26 and has also been added to the defined media as a culture requirement of neonatal rat OECs2, we evaluated whether this could be responsible for possibly stimulating the expression of iNOS.
In order to investigate the presumptive regulation of the pneumococcal infection in OECs, uninfected and infected cultures were incubated or not with rIFN-γ (100 U/mL) for 18 h and the percentage of infected cells was determined after the interaction step. The glass coverslips were then removed from each well and mounted on glass slides with N-propylgallate in PBS-glycerol. Samples were analyzed using a Zeiss epifluorescence photomicroscope (Zeiss, Jena, Germany) and a set of 200 cells was examined for the presence of S. pneumoniae. In addition, the percentage of cells with associated bacteria (adhered or internalized) was calculated as follows: number of infected cells/200 cells × 100.
Quantitative RT-PCR analysis of iNOS mRNA expression in OEC cultures uninfected and infected by Streptococcus pneumoniae
Total RNA was extracted from infected and uninfected OEC cultures at a density of 3 × 106 cells per dish using Trizol reagent (Invitrogen)27. RNA concentration was measured by spectrophotometry in a Nanodrop ND-1000 system. The synthesis of cDNA from mRNA was performed by using the SuperScrip III first-strand synthesis system RT-PCR kit (Invitrogen) according to the manufacturer’s instructions. The cDNA obtained served as a template for PCR with gene specific primer sets. PCR primers for target genes were purchased (Invitrogen). The following pairs of primers were used to determine mRNA iNOS levels: forward 5′- CAGCTGGGCTGTACAAACCTT-3′ and reverse 5′-CATTGGAAGTGAAGCGTTTCG-3′. GAPDH forward 5′-TGCACCACCACCTGCTTAGC-3′ and GAPDH reverse 5′-GGCATGGACTGTGGTC ATGAG-3′ were used for normalization. Relative mRNA levels were measured with a iTaq Universal SYBR green Supermix detection system using ABI 7500 Real-Time PCR (Applied Biosystems, Foster City, CA, USA). Quantitative RT-PCR was performed to measure the relative levels of expression of iNOS gene in the infected and uninfected OEC cultures. The entire set of experiments was performed three times. For each sample, the expression of each gene was normalized to the expression of the housekeeping gene GAPDH using the 2−ΔΔCt method, where ΔCt = Ct, reference gene; Ct, target gene.
Ultrastructural analysis of OECs and microglia after interaction with S. pneumoniae
Infected cultures were rinsed in PBS five times to remove nonadhered S. pneumoniae and immediately fixed in 2.5% (v/v) glutaraldehyde in 0.1 M sodium cacodylate buffer pH 7.2 at 4 °C for 1 h. Cells were scraped out of the dishes on ice, centrifuged at 900 × g for 10 min, and post-fixed in 1% osmium tetroxide (Sigma) in 0.1 M sodium cacodylate buffer containing 3.5% sucrose at 4 °C for 30 min. Cells were then washed in the same buffer, dehydrated in acetone, and embedded in PolyBed 812 (Polyscience, Philadelphia, PA, USA). Thin sections were obtained in an OmU3 Reichert ultramicrotome, stained with aqueous 2% uranyl acetate, and examined in a Zeiss EM 10C transmission electron microscope.
Statistical analyses of the data from the assays of viability, NF-κB translocation and cell/bacteria association were performed with One-way ANOVA followed by the Tukey test for multiple comparisons. For measurement of nitrite concentration, Two-way ANOVA was applied, followed by Bonferroni post-test. Data from quantitative RT-PCR were compared by Student’s t-test of uninfected vs. infected OEC cultures. Data were analyzed using PRISM (Version 5.01, Graph Pad Software, La Jolla, CA, USA). P values equal to or less than 0.05 were considered statistically significant.
How to cite this article: Macedo-Ramos, H. et al. Streptococcus pneumoniae resists intracellular killing by olfactory ensheathing cells but not by microglia. Sci. Rep. 6, 36813; doi: 10.1038/srep36813 (2016).
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Doucette, J. R. The glial cells in the nerve fiber layer of the rat olfactory bulb. Anat Rec 210, 385–391 (1984).
Barnett, S. C. Olfactory ensheathing cells: unique glial cell types? J. Neurotrauma 21, 375–382 (2004).
Raisman, G. & Li, Y. Repair of neural pathways by olfactory ensheathing cells. Nat. Rev. Neurosci. 8, 312–319 (2007).
Vincent, A. J., Choi-Lundberg, D. L., Harris, J. A., West, A. K. & Meng, I. C. Bacteria and PAMPs activate nuclear factor κB and Gro production in a subset of olfactory ensheathing cells and astrocytes but not in Schwann cells. Glia 55, 905–916 (2007).
Leung, J. Y. K. et al. Olfactory ensheathing cells are attracted to, and can endocytose, bacteria. Cell. Mol. Life Sci. 65, 2732–2739 (2008).
Harris, J. A., West, A. K. & Chuah, M. I. Olfactory ensheathing cells: Nitric oxide production and innate immunity. Glia 57, 1848–1857 (2009).
Macedo-Ramos, H. et al. Olfactory ensheathing cells as putative host cells for Streptococcus pneumoniae: Evidence of bacterial invasion via mannose receptor-mediated endocytosis. Neurosci. Res. 69, 308–313 (2011).
Brandt, C. T. et al. Impact of bacteremia on the pathogenesis of experimental pneumococcal meningitis. J. Infect. Dis. 197, 235–244 (2008).
Weiser, J. N. The pneumococcus: Why a commensal misbehaves. J. Mol. Med. 88, 97–102 (2010).
van Ginkel, F. W. et al. Pneumococcal carriage results in ganglioside-mediated olfactory tissue infection. Proc. Natl. Acad. Sci. USA 100, 14363–14367 (2003).
Ruiz-Mendoza, S. et al. Streptococcus pneumoniae infection regulates expression of neurotrophic factors in the olfactory bulb and cultured olfactory ensheathing cells. Neuroscience 317, 149–161 (2016).
Burudi, E. M., Riese, S., Stahl, P. D. & Régnier-Vigouroux, a. Identification and functional characterization of the mannose receptor in astrocytes. Glia 25, 44–55 (1999).
Beiter, K. et al. An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps. Curr. Biol. 16, 401–407 (2006).
Lundberg, J. O., Weitzberg, E. & Gladwin, M. T. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat. Rev. Drug Discov. 7, 156–167 (2008).
Shepherd Virginia L., Cowan Hanson B. & Abdolrasulnia Rasul, V. S. Dexamethasone blocks the interferon-γ-mediated Downregulation of the macrophage Mannose Receptor. Arch. Biochem. Biophys. 312, 367–374 (1994).
Su, Z. et al. Olfactory ensheathing cells: The primary innate immunocytes in the olfactory pathway to engulf apoptotic olfactory nerve debris. Glia 61, 490–503 (2013).
Witheford, M., Westendorf, K. & Roskams, A. J. Olfactory ensheathing cells promote corticospinal axonal outgrowth by a L1 CAM-dependent mechanism. Glia 61, 1873–1889 (2013).
Kim, K. S. Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat. Rev. Neurosci. 4, 376–385 (2003).
Nash, H. H., Borke, R. C. & Anders, J. J. New method of purification for establishing primary cultures of ensheathing cells from the adult olfactory bulb. Glia 34, 81–87 (2001).
Carvalho, L. A. et al. Selective stimulatory action of olfactory ensheathing glia-conditioned medium on oligodendroglial differentiation, with additional reference to signaling mechanisms. Biochem. Biophys. Res. Commun. 449, 338–343 (2014).
Committee. in Guide for the Care and Use of Laboratory Animals, doi: 10.2307/1525495 118 (2011).
Righi, M. et al. Monokine production by microglial cell clones. Eur. J. Immunol. 19, 1443–1448 (1989).
Briles, D. E., Crain, M. J., Gray, B. M., Forman, C. & Yother, J. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect. Immun. 60, 111–116 (1992).
Di Fabio, J. L. et al. Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigía Group, 1993 to 1999. PAHO Sireva-Vigía Study Group. Pan American Health Organization. Pediatr. Infect. Dis. J. 20, 959–967 (2001).
Bernatowicz, A., Ködel, U., Frei, K., Fontana, A. & Pfister, H. walter. Production of nitrite by primary rat astrocytes in response to pneumococci. J. Neuroimmunol. 60, 53–61 (1995).
Ogawa, M. et al. Theophylline potentiates lipopolysaccharide-induced NO production in cultured astrocytes. Neurochem. Res. 39, 107–116 (2014).
Hummon, A. B., Lim, S. R., Difilippantonio, M. J. & Ried, T. Isolation and solubilization of proteins after TRIZOL?? extraction of RNA and DNA from patient material following prolonged storage. Biotechniques 42, 467–472 (2007).
Financial support for this study was provided by the Brazilian Council for Science and Technology (CNPq – Brazil), and the Carlos Chagas Filho Rio de Janeiro State Foundation for Research Support (FAPERJ – Brazil). We are grateful to Dr. Grasiella M. Ventura for her assistance in obtaining the confocal images. We also thank Professor Leny A. Cavalcante for having initiated the development of a method to isolate and culture highly purified populations of olfactory ensheathing cells without which this work would not have been possible.
The authors declare no competing financial interests.
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Macedo-Ramos, H., Ruiz-Mendoza, S., Mariante, R. et al. Streptococcus pneumoniae resists intracellular killing by olfactory ensheathing cells but not by microglia. Sci Rep 6, 36813 (2016). https://doi.org/10.1038/srep36813
This article is cited by
Neutrophil evasion strategies by Streptococcus pneumoniae and Staphylococcus aureus
Cell and Tissue Research (2018)
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.